Literature DB >> 23236561

MicroRNA expression profiles in differentiated thyroid cancer, a review.

Xinying Li1, Asim B Abdel-Mageed, Debasis Mondal, Emad Kandil.   

Abstract

MicroRNAs (miRNAs) are a class of short endogenous non-coding RNAs regulating gene expression in many biological processes, including proliferation, apoptosis and differentiation. The deregulation of miRNA expression is believed to be an important regulator of tumor development and progression of thyroid cancer. In this review, we discussed important roles and expression profiles of miRNA in differentiated thyroid cancer (DTC) as well as the promising implication in clinical practice.

Entities:  

Keywords:  Differentiated thyroid cancer; fine needle aspiration biopsy; microRNA; mutations

Year:  2012        PMID： 23236561      PMCID： PMC3515973     

Source DB:  PubMed          Journal:  Int J Clin Exp Med        ISSN： 1940-5901


  35 in total

1.  Development of a microRNA-based molecular assay for the detection of papillary thyroid carcinoma in aspiration biopsy samples.

Authors:  Haggi Mazeh; Ido Mizrahi; David Halle; Nadia Ilyayev; Alexander Stojadinovic; Barry Trink; Stella Mitrani-Rosenbaum; Marina Roistacher; Ilana Ariel; Ahmed Eid; Herbert R Freund; Aviram Nissan
Journal:  Thyroid       Date:  2011-02       Impact factor: 6.568

2.  The role of microRNA genes in papillary thyroid carcinoma.

Authors:  Huiling He; Krystian Jazdzewski; Wei Li; Sandya Liyanarachchi; Rebecca Nagy; Stefano Volinia; George A Calin; Chang-Gong Liu; Kaarle Franssila; Saul Suster; Richard T Kloos; Carlo M Croce; Albert de la Chapelle
Journal:  Proc Natl Acad Sci U S A       Date:  2005-12-19       Impact factor: 11.205

3.  Detection of the PAX8-PPARgamma fusion protein in thyroid tumors.

Authors:  Ronald J Koenig
Journal:  Clin Chem       Date:  2010-01-14       Impact factor: 8.327

4.  Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer.

Authors:  David S Cooper; Gerard M Doherty; Bryan R Haugen; Bryan R Hauger; Richard T Kloos; Stephanie L Lee; Susan J Mandel; Ernest L Mazzaferri; Bryan McIver; Furio Pacini; Martin Schlumberger; Steven I Sherman; David L Steward; R Michael Tuttle
Journal:  Thyroid       Date:  2009-11       Impact factor: 6.568

5.  MicroRNA signature in thyroid fine needle aspiration cytology applied to "atypia of undetermined significance" cases.

Authors:  Rulong Shen; Sandya Liyanarachchi; Wei Li; Paul E Wakely; Motoyasu Saji; Jie Huang; Rebecca Nagy; Tisha Farrell; Matthew D Ringel; Albert de la Chapelle; Richard T Kloos; Huiling He
Journal:  Thyroid       Date:  2011-12-02       Impact factor: 6.568

6.  MicroRNA expression profiles classify human cancers.

Authors:  Jun Lu; Gad Getz; Eric A Miska; Ezequiel Alvarez-Saavedra; Justin Lamb; David Peck; Alejandro Sweet-Cordero; Benjamin L Ebert; Raymond H Mak; Adolfo A Ferrando; James R Downing; Tyler Jacks; H Robert Horvitz; Todd R Golub
Journal:  Nature       Date:  2005-06-09       Impact factor: 49.962

7.  RAS point mutations and PAX8-PPAR gamma rearrangement in thyroid tumors: evidence for distinct molecular pathways in thyroid follicular carcinoma.

Authors:  Marina N Nikiforova; Roy A Lynch; Paul W Biddinger; Erik K Alexander; Gerald W Dorn; Giovanni Tallini; Todd G Kroll; Yuri E Nikiforov
Journal:  J Clin Endocrinol Metab       Date:  2003-05       Impact factor: 5.958

8.  In vivo imaging of functional targeting of miR-221 in papillary thyroid carcinoma.

Authors:  Hyun Joo Kim; Young Ha Kim; Dong Soo Lee; June-Key Chung; Soonhag Kim
Journal:  J Nucl Med       Date:  2008-09-15       Impact factor: 10.057

9.  MicroRNAs (miR)-221 and miR-222, both overexpressed in human thyroid papillary carcinomas, regulate p27Kip1 protein levels and cell cycle.

Authors:  Rosa Visone; Lucia Russo; Pierlorenzo Pallante; Ivana De Martino; Angelo Ferraro; Vincenza Leone; Eleonora Borbone; Fabio Petrocca; Hansjuerg Alder; Carlo Maria Croce; Alfredo Fusco
Journal:  Endocr Relat Cancer       Date:  2007-09       Impact factor: 5.678

10.  PAX8 and peroxisome proliferator-activated receptor gamma 1 gene expression status in benign and malignant thyroid tissues.

Authors:  Ludovic Lacroix; Caterina Mian; Thierry Barrier; Monique Talbot; Bernard Caillou; Martin Schlumberger; Jean-Michel Bidart
Journal:  Eur J Endocrinol       Date:  2004-09       Impact factor: 6.664
View more
  21 in total

Review 1.  Molecular markers in well-differentiated thyroid cancer.

Authors:  Anil K D'Cruz; Richa Vaish; Abhishek Vaidya; Iain J Nixon; Michelle D Williams; Vincent Vander Poorten; Fernando López; Peter Angelos; Ashok R Shaha; Avi Khafif; Alena Skalova; Alessandra Rinaldo; Jennifer L Hunt; Alfio Ferlito
Journal:  Eur Arch Otorhinolaryngol       Date:  2018-04-06       Impact factor: 2.503

2.  Significance of CK19, TPO, and HBME-1 expression for diagnosis of papillary thyroid carcinoma.

Authors:  Zeming Liu; Pan Yu; Yiquan Xiong; Wen Zeng; Xiaoyu Li; Yusufu Maiaiti; Shuntao Wang; Haiping Song; Lan Shi; Chunping Liu; Bo Cheng; Bo Zhang; Jie Ming; Fang Dong; Hui Ge; Xiu Nie; Tao Huang
Journal:  Int J Clin Exp Med       Date:  2015-03-15

3.  MicroRNA-29a functions as a potential tumor suppressor through directly targeting CDC42 in non-small cell lung cancer.

Authors:  Yongqiang Li; Zhi Wang; Yijiang Li; Ruijun Jing
Journal:  Oncol Lett       Date:  2017-03-22       Impact factor: 2.967

4.  microRNA-494 is a potential prognostic marker and inhibits cellular proliferation, migration and invasion by targeting SIRT1 in epithelial ovarian cancer.

Authors:  Aijun Yang; Xuenan Wang; Chunna Yu; Zhenzhen Jin; Lingxia Wei; Jinghe Cao; Qin Wang; Min Zhang; Lin Zhang; Lei Zhang; Cuifang Hao
Journal:  Oncol Lett       Date:  2017-06-30       Impact factor: 2.967

5.  Genome-wide analysis of differentially expressed miRNA in PLX4720-resistant and parental human thyroid cancer cell lines.

Authors:  Shohreh Varmeh; Pierre Vanden Borre; Viswanath Gunda; Eran Brauner; Tammy Holm; Yangun Wang; Ruslan Ilyasovich Sadreyev; Sareh Parangi
Journal:  Surgery       Date:  2015-10-09       Impact factor: 3.982

6.  MicroRNA-146b-3p Promotes Cell Metastasis by Directly Targeting NF2 in Human Papillary Thyroid Cancer.

Authors:  Chunxiao Yu; Li Zhang; Dandan Luo; Fang Yan; Jia Liu; Shanshan Shao; Lifang Zhao; Tong Jin; Jiajun Zhao; Ling Gao
Journal:  Thyroid       Date:  2018-10-27       Impact factor: 6.568

Review 7.  Non-Coding RNAs in Thyroid Cancer.

Authors:  Ranran Zhang; Heather Hardin; Jidong Chen; Zhenying Guo; Ricardo V Lloyd
Journal:  Endocr Pathol       Date:  2016-03       Impact factor: 3.943

8.  Inhibition of microRNA-875-5p promotes radioiodine uptake in poorly differentiated thyroid carcinoma cells by upregulating sodium-iodide symporter.

Authors:  Y Tang; X Meng; X Yu; H Shang; S Chen; L Liao; J Dong
Journal:  J Endocrinol Invest       Date:  2019-10-14       Impact factor: 5.467

9.  Serum microRNA profiling to distinguish papillary thyroid cancer from benign thyroid masses.

Authors:  M Elise R Graham; Robert D Hart; Susan Douglas; Fawaz M Makki; Devanand Pinto; Angela L Butler; Martin Bullock; Matthew H Rigby; Jonathan R B Trites; S Mark Taylor; Rama Singh
Journal:  J Otolaryngol Head Neck Surg       Date:  2015-09-05

Review 10.  MicroRNAs and Chinese Medicinal Herbs: New Possibilities in Cancer Therapy.

Authors:  Ming Hong; Ning Wang; Hor Yue Tan; Sai-Wah Tsao; Yibin Feng
Journal:  Cancers (Basel)       Date:  2015-08-24       Impact factor: 6.639
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.